🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆ Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆
Updated 13 Sep 2026 · ClinicalTrials.gov

Clinical Trials in Cork

← All Irish trials

Every active and recruiting clinical study with an Irish site — searchable by condition, sponsor, phase and location. Refreshed daily from the ClinicalTrials.gov registry.

12
Recruiting now
27
Active studies
Recruiting Phase 3
A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
Myelofibrosis, Anemia
Takeda · started 2026-09-02
Cork · Dublin · Galway
NCT07623161 on ClinicalTrials.gov ↗
Starting soon
An Intervention Study in Healthy Infants Aged 0-6 Months With Probiotics Lacticaseibacillus Rhamnosus LRa05 (LRa05) and Bifidobacterium Animalis Subsp. Lactis BLa80 (BLa80) vs. Placebo, for Promoting Gut Microbiome Development.
Less Than 3 Months Old, Healthy Infants
University College Cork · started 2026-04
Cork
NCT07505329 on ClinicalTrials.gov ↗
Starting soon
Improving ADHD Symptoms and Quality of Life Through Diet
ADHD
University College Cork · started 2026-02
Cork
NCT07376746 on ClinicalTrials.gov ↗
Recruiting
Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergoing Upfront Tailored Axillary Surgery
Breast Cancer
University Hospital, Basel, Switzerland · started 2026-01-01
Cork · Dublin · Galway
NCT07140172 on ClinicalTrials.gov ↗
Recruiting Phase 3
AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer
Epithelial Ovarian Cancer
AstraZeneca · started 2025-12-29
Cork · Dublin · Waterford
NCT07218809 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study to Learn How Safe and How Well Linvoseltamab Works Compared to Standard Treatment in Adult Patients With Multiple Myeloma Who Are Not Eligible for Transplant
Multiple Myeloma
European Myeloma Network B.V. · started 2025-12-23
Cork · Dublin · Limerick
NCT06932562 on ClinicalTrials.gov ↗
Recruiting
AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions
Coronary Arterial Disease (CAD), de Novo Lesions in Native Coronary Arteries
Boston Scientific Corporation · started 2025-08-21
Cork · Dublin · Galway
NCT06959524 on ClinicalTrials.gov ↗
Active Phase 3
Safety Study of Viaskin® Peanut Patch in Peanut-Allergic Children 1 Through 3 Years of Age (COMFORT Toddlers)
Allergy, Peanut Allergy
DBV Technologies · started 2025-06-24
Cork · Dublin
NCT07003919 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
Myelodysplastic Syndromes
Takeda · started 2025-05-06
Cork · Dublin · Limerick
NCT06499285 on ClinicalTrials.gov ↗
Recruiting
AI-driven Narrow-band Imaging Score for Disease Assessment and Outcome Prediction in Ulcerative Colitis
Ulcerative Colitis (UC)
University College Cork · started 2024-11-04
Cork
NCT06709209 on ClinicalTrials.gov ↗
Active Phase 3
A Study to Compare Sacituzumab Tirumotecan (MK-2870) Monotherapy Versus Treatment of Physician's Choice as Second-line Treatment for Participants With Recurrent or Metastatic Cervical Cancer (MK-2870-020/TroFuse-020/Gog-3101/ENGOT-cx20)
Cervical Cancer
Merck Sharp & Dohme LLC · started 2024-07-24
Cork · Dublin
NCT06459180 on ClinicalTrials.gov ↗
Recruiting Phase 3
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Triple-Negative Breast Cancer
Merck Sharp & Dohme LLC · started 2024-06-24
Cork · Dublin · Galway
NCT06393374 on ClinicalTrials.gov ↗
Recruiting
A Study of Clinical Outcomes in Patients With Relapsed/Refractory Multiple Myeloma (RRMM) Treated With T-cell Redirectors Outside of Clinical Trials
Relapsed/Refractory Multiple Myeloma (RRMM)
Janssen-Cilag Ltd. · started 2023-12-18
Cork · Dublin · Galway
NCT06285318 on ClinicalTrials.gov ↗
Recruiting
Discontinuation Study
Multiple Myeloma, Cancer, Hematologic Cancer
University College Cork · started 2023-08-28
Cork
NCT05866757 on ClinicalTrials.gov ↗
Active
Ultimaster Nagomi™ Sirolimus Eluting Coronary Stent System in Complex PCI Patients
Cardiovascular Disease, Coronary Artery Occlusion, Ischemic Heart Disease
Terumo Europe N.V. · started 2023-04-25
Cork · Dublin · Galway
NCT05705973 on ClinicalTrials.gov ↗
Active Phase 3
A Study to Learn More About How Well Elinzanetant Works and How Safe it is Compared to Placebo for the Treatment of Hot Flashes Caused by Anti-cancer Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast Cancer
Vasomotor Symptoms Caused by Adjuvant Endocrine Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast Cancer, Hot Flashes
Bayer · started 2022-10-14
Galway · Dublin · Cork · Waterford
NCT05587296 on ClinicalTrials.gov ↗
Active Phase 3
A Phase III Study of Ceralasertib Plus Durvalumab Versus Docetaxel in Patients With Non Small Cell Lung Cancer (NSCLC) Whose Disease Progressed On or After Prior Anti PD (L)1 Therapy And Platinum Based Chemotherapy
Advanced or Metastatic Non-Small Cell Lung Cancer
AstraZeneca · started 2022-09-15
Cork · Dublin · Limerick
NCT05450692 on ClinicalTrials.gov ↗
Active Phase 3
A Research Study to Compare Somapacitan Once a Week With Norditropin® Once a Day in Children Who Need Help to Grow
SGA, Turner Syndrome, Noonan Syndrome, ISS
Novo Nordisk A/S · started 2022-08-10
Cork · Dublin
NCT05330325 on ClinicalTrials.gov ↗
Recruiting
Effect of Probiotic Limosilactobacillus Reuteri (L. Reuteri) on Crying Time in Infants With Colic
Colic, Infantile
BioGaia AB · started 2022-07-13
Cork
NCT05512234 on ClinicalTrials.gov ↗
Active Phase 3
Open-label Study Comparing Iberdomide, Daratumumab and Dexamethasone (IberDd) Versus Daratumumab, Bortezomib, and Dexamethasone (DVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
Multiple Myeloma
Celgene · started 2022-06-23
Cork · Dublin · Galway
NCT04975997 on ClinicalTrials.gov ↗
Recruiting Phase 2/Phase 3
(HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis
Indolent Systemic Mastocytosis, Smoldering Systemic Mastocytosis
Blueprint Medicines Corporation · started 2021-11-30
Cork
NCT04910685 on ClinicalTrials.gov ↗
Active Phase 3
Trastuzumab Deruxtecan for Subjects With HER2-Positive Gastric Cancer or Gastro-Esophageal Junction Adenocarcinoma After Progression on or After a Trastuzumab-Containing Regimen (DESTINY-Gastric04)
Gastric Cancer, Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma
Daiichi Sankyo · started 2021-05-21
Cork · Dublin
NCT04704934 on ClinicalTrials.gov ↗
Active Phase 3
A Study of Inebilizumab Efficacy and Safety in IgG4- Related Disease
IgG4 Related Disease
Amgen · started 2020-12-04
Cork
NCT04540497 on ClinicalTrials.gov ↗
Active Phase 2
A Study of Belzutifan (MK-6482) in Participants With Advanced Renal Cell Carcinoma (MK-6482-013)
Carcinoma, Renal Cell
Merck Sharp & Dohme LLC · started 2020-09-13
Cork · Dublin
NCT04489771 on ClinicalTrials.gov ↗
Active Phase 3
A Study of Ivosidenib or Enasidenib in Combination With Induction Therapy and Consolidation Therapy, Followed by Maintenance Therapy in Patients With Newly Diagnosed Acute Myeloid Leukemia or Myedysplastic Syndrome EB2, With an IDH1 or IDH2 Mutation, Respectively, Eligible for Intensive Chemotherapy
Acute Myeloid Leukemia, Myelodysplastic Syndrome With Excess Blasts-2
Stichting Hemato-Oncologie voor Volwassenen Nederland · started 2019-03-01
Cork · Dublin · Galway
NCT03839771 on ClinicalTrials.gov ↗
Active Phase 3
Study of Pembrolizumab (MK-3475) Versus Placebo in Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (MK-3475-756/KEYNOTE-756)
Breast Cancer
Merck Sharp & Dohme LLC · started 2018-12-27
Cork · Dublin
NCT03725059 on ClinicalTrials.gov ↗
Active Phase 3
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
Breast Ductal Carcinoma In Situ, Invasive Breast Carcinoma, Multicentric Breast Carcinoma, Multifocal Breast Carcinoma
National Cancer Institute (NCI) · started 2011-02-28
Cork · Dublin · Mount Merrion · Galway · Limerick · Sligo
NCT01272037 on ClinicalTrials.gov ↗
No trials match your search.

Browse by location

Dublin · 75 Cork · 27 Galway · 20 Limerick · 6 Waterford · 4 Ballinasloe · 3 Sligo · 2 Carlow · 1 Wilton · 1 County Limerick · 1 Tallaght · 1 Dunmore RoadWaterford · 1

Browse by condition

Breast Cancer · 5 Multiple Myeloma · 4 Heart Failure · 3 Cancer · 3 Down Syndrome · 2
Cite this page

Priya Life Science (2026). Clinical Trials in Ireland Tracker. Available at: https://priyalifescience.com/clinical-trials-ireland/city/cork (Accessed: 13 September 2026).

Embed this data ↗

Source: ClinicalTrials.gov, U.S. National Library of Medicine — studies listing at least one Irish site, refreshed daily. Listing here is informational and not medical advice; eligibility is determined by each study team. Patients should discuss participation with their clinician. For trials across the wider EU, see our EU Clinical Trials Tracker.